Vezzoni P, Fiacchino F, Clerici L, Sghirlanzoni A, Cerrato D, Peluchetti D, Lucchini R, Raineri M, Cornelio F
J Neuroimmunol. 1984 Sep-Oct;6(6):427-33. doi: 10.1016/0165-5728(84)90067-5.
Thymic function in myasthenic patients was examined using two biochemical markers which specifically define a population of cortisone-sensitive cortical thymocytes. The enzymatic activities of terminal deoxynucleotidyl transferase (TdT) and adenosine deaminase (ADA) were determined in 13 samples. High contents of both enzymes were found in young patients. The enzymatic activities were easily detectable also in the oldest patients, despite the morphological involution and the decrease in TdT which are known to occur with age in the normal thymus. TdT and ADA-containing cells were almost completely depleted in all the 3 treated patients by the corticosteroid treatment which provides a non-surgical alternative to the elimination of this lymphoid population by thymectomy. The persistence of TdT and ADA activity in old age, and their inhibition by the corticosteroid treatment.
使用两种生化标志物对重症肌无力患者的胸腺功能进行了检测,这两种标志物可特异性地界定一群对可的松敏感的皮质胸腺细胞。在13份样本中测定了末端脱氧核苷酸转移酶(TdT)和腺苷脱氨酶(ADA)的酶活性。在年轻患者中发现这两种酶的含量都很高。尽管正常胸腺会随着年龄增长出现形态退化和TdT减少,但在年龄最大的患者中也很容易检测到酶活性。在所有3例接受治疗的患者中,通过皮质类固醇治疗,含TdT和ADA的细胞几乎完全耗尽,这为胸腺切除术消除这群淋巴细胞提供了一种非手术替代方法。TdT和ADA活性在老年时持续存在,且会受到皮质类固醇治疗的抑制。